Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Espinoza

Phlebology Lexington, SC Medical Doctor

NPI 1780613455 CMS profile 81112

117 Park Place Ct, Lexington, SC 29072

Open in the dashboard

General payments

$3,472

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Espinoza of Lexington, SC is reported in the CMS Open Payments database as having received $3,472 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Phlebology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $878 16
2024 General $992 19
2023 General $207 6
2022 General $440 10
2021 General $77 4
2020 General $70 4
2019 General $808 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Espinoza
  • Phlebology median
  • Middle half of Phlebology
  • National median

In program year 2025, general payments to Paul Espinoza were reported at $878. Among 79 Phlebology profiles paid that year, the median was $146 and the middle half received between $41 and $404.

Show as a table
Year Paul Espinoza Phlebology median Middle half National median
2019 $808 $184 $47–$602 $163
2020 $70 $129 $64–$375 $114
2021 $77 $144 $48–$585 $132
2022 $440 $171 $46–$575 $149
2023 $207 $207 $37–$633 $160
2024 $992 $175 $53–$445 $164
2025 $878 $146 $41–$404 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tactile Systems Technology Inc $879 30 payments
  2. Boston Scientific Corporation $708 14 payments
  3. Bard Peripheral Vascular, Inc. $362 5 payments
  4. Organogenesis Inc. $351 5 payments
  5. Medtronic, Inc. $313 3 payments
  6. Inari Medical, Inc. $298 3 payments
  7. Biocompatibles, Inc. $242 7 payments
  8. Medtronic Vascular, Inc. $241 2 payments
  9. Cashflow Solutions, LLC $65 4 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,472 74 payments
Products named General payments · program years 2019–2025
  1. Flexitouch Plus $633 24 payments
  2. Varithena Administration Pack $534 9 payments
  3. Entre Plus $410 13 payments
  4. Venclose Maven Catheter $336 4 payments
  5. FLOWTRIEVER CATHETER, S $298 3 payments
  6. CT THROMBECTOMY SYSTEM KIT $298 3 payments
  7. FLEXITOUCH $246 6 payments
  8. ACTITOUCH $246 6 payments
  9. ENTRE $246 6 payments
  10. VARITHENA $242 7 payments
  11. Other $1,504 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$552,619

Medicare's payments for the services billed

Medicare patients

594

Average age 74

Services billed

3,891

420 women, 174 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 26%
Ischemic heart disease 26%
Atrial fibrillation 16%
Depression 16%
Chronic kidney disease 13%
Cancer 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Phlebology in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record